Catalyst Wire Dossier Catalyst Wire Dossier

Investigational compound(s) platform study

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational compound(s) platform study, covering 2025-12-22 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]

See pricing